541 - 550 of 8399 Results
Title
Year
- Very low levels of ABCA7 in the cerebrum and Alzheimer’s disease onset between the ages of 60 and 80 independently of APOE2024RESTRICTEDTitle: Very low levels of ABCA7 in the cerebrum and Alzheimer’s disease onset between the ages of 60 and 80 independently of APOEJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 83Issue #: 10Start Page: 808End Page: 821Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlae060Citation Count: 0
- The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson’s disease patient iPSC derived midbrain neurons2024OPENTitle: The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson’s disease patient iPSC derived midbrain neuronsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-49256-3Best OA location URL: https://www.nature.com/articles/s41467-024-49256-3.pdfCitation Count: 5
- Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onset2024OPENTitle: Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onsetJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-48961-3Best OA location URL: https://www.nature.com/articles/s41467-024-48961-3.pdfCitation Count: 30
- Plasma pTau181 Reveals a Pathological Signature that Predicts Cognitive Outcomes in Lewy Body Disease2024OPENTitle: Plasma pTau181 Reveals a Pathological Signature that Predicts Cognitive Outcomes in Lewy Body DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 96Issue #: 3Start Page: 526End Page: 538Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.27003Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.27003Citation Count: 3
- Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson disease2024OPENTitle: Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson diseaseJournal Name: Nature Mental HealthPublisher: Springer Science and Business Media LLCVol: 2Issue #: 8Start Page: 916End Page: 923Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s44220-024-00256-8Best OA location URL: https://www.nature.com/articles/s44220-024-00256-8.pdfCitation Count: 2
- Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia2024OPENTitle: Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementiaJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 111Issue #: 7Start Page: 1316End Page: 1329Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ajhg.2024.05.017Best OA location URL: https://doi.org/10.1016/j.ajhg.2024.05.017Citation Count: 1
- Neurovascular and immune factors of vulnerability of substantia nigra dopaminergic neurons in non-human primates2024OPENTitle: Neurovascular and immune factors of vulnerability of substantia nigra dopaminergic neurons in non-human primatesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00735-wBest OA location URL: https://www.nature.com/articles/s41531-024-00735-w.pdfCitation Count: 2
- Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology2024OPENTitle: Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathologyJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-49402-xBest OA location URL: https://doi.org/10.1038/s41467-024-49402-xCitation Count: 18
- Neuropathological findings and in vivo imaging correlates of the red nucleus compared to those of the substantia nigra pars compacta in parkinsonisms2024RESTRICTEDTitle: Neuropathological findings and in vivo imaging correlates of the red nucleus compared to those of the substantia nigra pars compacta in parkinsonismsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 125Issue #:Start Page: 107043End Page: 107043Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107043Citation Count: 1
- Selection of DNA aptamers that prevent the fibrillization of α-synuclein protein in cellular and mouse models2024RESTRICTEDTitle: Selection of DNA aptamers that prevent the fibrillization of α-synuclein protein in cellular and mouse modelsJournal Name: Molecular Therapy - Nucleic AcidsPublisher: Elsevier BVVol: 35Issue #: 3Start Page: 102251End Page: 102251Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtn.2024.102251Citation Count: 2